Similar findings were reported in the HEEL trial with a positive trend although not statistically significant for etanercept vs placebo in oedema extension from baseline to week 12 [ 22 ].
← all excerpts
Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial.
1
—
—